IBD: More Patients on Vedolizumab vs Anti-TNFs at 2 Years
COPENHAGEN – Vedolizumab (ENTYVIO) a monoclonal antibody drug, shows a higher overall 1- and 2-year persistence of use – the overall time
Read more
COPENHAGEN – Vedolizumab (ENTYVIO) a monoclonal antibody drug, shows a higher overall 1- and 2-year persistence of use – the overall time
Read moreWe include products we think are useful for our readers. If you buy through links on this page, we may
Read moreYou may want to sit down for this one. And pour yourself a hot drink, or an alcoholic beverage. Just
Read moreBritish Heart Foundation: Understanding blood clots We use your sign-up to provide content in ways you’ve consented to and to
Read moreNearly 2 years after a whistleblower alleged that the University of Pittsburgh Medical Center (UPMC) and its head of cardiothoracic
Read moreMagnetic resonance imaging (MRI) has allowed scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) to produce an accurate picture
Read morePHILIPSBURG, Mont. — On a recent day in this 19th-century mining town turned tourist hot spot, students made their way
Read moreIn a recent study published in Nature Cardiovascular Research, researchers estimated excess cardiovascular deaths in the United States of America
Read moreExact number of steps needed to burn off your favourite alcoholic drink revealed – and it’s bad news for cider
Read moreRare skin-blistering disease spread by CATS is spotted in Britain for first time ever EXCLUSIVE: Cat-transmitted sporotrichosis has been found
Read more